JPEO-CBRND & BARDA Commercial Solutions Opening (CSO) Area of Interest (AoI) W911QY-20-S-C001-A002 Neutralization Assay
Closed Special Notice Posted
Not the latest version. See the latest solicitation from .
- Agency
-
ACC Aberdeen Proving Ground
Army Contracting Command, Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 541380 Testing Laboratories and Services
- Place of performance
- Natick MA 01760 USA
Notice details come from SAM.gov. Updated .
About this opportunity
This Special Notice announces a potential new Area of Interest under the Commercial Solutions Opening solicitation issued by the U.S. Army Contracting Command - Aberdeen Proving Ground, Natick Division on behalf of the Joint Program Executive Office - Chemical Biological Radiological Nuclear Defense and Biomedical Advanced Research and Development Authority, Department of Health and Human Services. The Special Notice seeks the validation and transfer of a SARS-CoV-2 virus specific neutralization assay, as well as testing services using the validated assay, in support of Operation Warp Speed and the COVID-19 response.
The purpose of this Special Notice is to provide advance notice of a potential Area of Interest focused on completing the validation and technology transfer of a qualified SARS-CoV-2 neutralization assay from a third party under appropriate biosafety conditions. Interested parties would then provide testing services to analyze serum samples using the validated assay in compliance with Good Clinical Laboratory Practice for FDA submission. The anticipated Area of Interest is expected to be posted on or around July 24, 2020. Interested contractors should monitor beta.sam.gov and are advised that the release of this Area of Interest is not guaranteed. The costs of proposal preparation will not be reimbursed by the government. Eligible parties include those able to complete the assay validation and transfer, and to provide the described testing services.
Notice text
Program Announcement: JPEO-CBRND & BARDA Commercial Solutions Opening (CSO) Area of Interest (AoI) W911QY-20-S-C001-A002 Neutralization Assay
Contracting Office: U.S. Army Contracting Command – Aberdeen Proving Ground, Natick Division (ACC-APG-Natick)
Program Office: Joint Program Executive Office - Chemical Biological Radiological Nuclear Defense (JPEO-CBRND) and Biomedical Advanced Research and Development Authority (BARDA), Department of Health and Human Services (HHS).
A. Background:
This is a Program Announcement for a potential new Area of Interest (AoI) against the U.S. Army Contracting Command – Aberdeen Proving Ground, Natick Division’s (ACC-APG-Natick) Commercial Solutions Opening (CSO) W911QY-20-S-C001 on behalf of Joint Program Executive Office - Chemical Biological Radiological Nuclear Defense (JPEO-CBRND) and Biomedical Advanced Research and Development Authority (BARDA), Department of Health and Human Services. The potential AoI is being prepared in support of Operation Warp Speed in response to the Corona Virus 2019 (COVID-19) Pandemic.
The anticipated AoI will utilize the non-Federal Acquisition Regulation (FAR) based solicitation authority for acquiring innovative and commercial solutions. Section 879 of the National Defense Authorization Act (NDAA) for Fiscal Year 2017 (Pub. L. 114-328) authorizes ACC-APG-Natick to implement a pilot program to competitively procure innovative commercial items, technologies, and services using CSO procedures. CSO is new acquisition mechanism that provides a streamlined acquisition process and simplified contract terms that is designed to attract start-up companies and others who have not previously worked with U.S. Government. Under the CSO and resulting AoI’s ACC-APG-Natick seeks proposals for innovative, commercial items, technologies and services currently in the production/commercialization phase as well as adaptations of existing commercial products to combat the current COVID-19 pandemic as well as future pandemics or medical emergencies. The current ACC-APG-Natick CSO solicitation is open and available through 30 September 2022. This is an advance notice of a potential second technical AoI posting for the validated SARS-CoV-2 virus specific neutralization assay.
The CSO solicitation process will include a multi-phased solicitation and evaluation approach: Phase 1 – Submission of the Written Solution Brief, Phase 2 – presentations/pitches (if applicable), and Phase 3 – Request for Commercial Solution Proposal. The CSO is considered a competitive process, intended to ensure that competitive procedures are used to the maximum extent practicable.
B. Potential Opportunities:
BARDA has a potential Area of Interest (AoI) to complete the following: technology transfer of a qualified or validated SARS-CoV-2 virus specific neutralization assay using a live SARS-CoV-2 virus from a third party under appropriate biosafety laboratory conditions; demonstrate comparability of the established assay to a previously validated assay established by a third party. Additionally, this AoI will seek to provide testing services to analyze serum samples using the validated SARS-CoV-2 virus specific neutralization assay in compliance with GCLP for submission to FDA. Interested parties are highly encouraged to visit beta.sam.gov regularly for updates and new postings.
Interested parties are hereby advised of the following:
The potential AoI is expected to be posted on or about July 24th 2020. The government reserves the right to release or not to release the potential AoI as a result of this program announcement.
A solicitation for solution briefs, presentations/pitches and requests for proposals are not a guarantee that award and obligation of funds will be made.
The costs incurred by companies in the preparation and submission of their solution briefs, presentations/pitches and requests for proposals in response to solicitations will not be paid by the government and are not allowable as a direct charge to any government contract.
C. Reference(s):
W911QY-20-S-C001
The Commercial Solutions Offering solicitation is currently open until 30 September 2022.
Notice history
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity